Cite
Abstract LB-317: Identification of a novel preclinical candidate for CDK7 inhibition
MLA
Leena Khare Satyam, et al. “Abstract LB-317: Identification of a Novel Preclinical Candidate for CDK7 Inhibition.” Cancer Research, vol. 77, July 2017, p. LB-317. EBSCOhost, https://doi.org/10.1158/1538-7445.am2017-lb-317.
APA
Leena Khare Satyam, Ravindra M, Dabbeeru Madhu Babu, Nandish C, Subhendu Mukherjee, Lakshmi Narayana Kaza, Shekar Chelur, Ramulu Poddutoori, Thomas Antony, Amith A, Sivapriya Marappan, Sreevalsam Gopinath, Manoj Pothuganti, Suraj Tgore, Shilpa S. Nayak, Chetan Pandit, Susanta Samajdar, Murali Ramachandra, Girish Daginakatte, … Nagaraju A. (2017). Abstract LB-317: Identification of a novel preclinical candidate for CDK7 inhibition. Cancer Research, 77, LB-317. https://doi.org/10.1158/1538-7445.am2017-lb-317
Chicago
Leena Khare Satyam, Ravindra M, Dabbeeru Madhu Babu, Nandish C, Subhendu Mukherjee, Lakshmi Narayana Kaza, Shekar Chelur, et al. 2017. “Abstract LB-317: Identification of a Novel Preclinical Candidate for CDK7 Inhibition.” Cancer Research 77 (July): LB-317. doi:10.1158/1538-7445.am2017-lb-317.